FindTrial
Sign In

Sugammadex And neostigmine recovery indices

Sugammadex and neostigmine recovery indices in pediatric patients undergoing adenotonsillectomy-A prospective randomized study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071709
Enrollment
128
Registered
2024-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 3- Administration Health Condition 2: 2- Placement

Interventions

Intervention1: Comparison of sugammadex and neostigmine to assess time required for extubation and postoperative parameters.: 2 hours, 4 hours and 6 hours of post extubation period. Control Interventi

Sponsors

VIRESH S KANNURE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1] 3-17 AGE GROUP PATIENTS POSTED FOR ADENOIDECTOMY AND TONSILLECTOMY. 2] ASA GRADE I AND II.

Exclusion criteria

Exclusion criteria: 1] ANY CARDIOVASCULAR AND HEPATIC IMPAIRMENT. 2] CREATININE CLEARANCE LESS THAN 30 MG/ML. 3] ALLERGIC TO ANY ANESTHETIC AGENT.

Design outcomes

Primary

MeasureTime frame
TO ASSESS THE POST OPERATIVE PARAMETER SUCH AS POST OP NAUSEA AND VOMITTING AFTER USING INJ.SUGAMMADEXTimepoint: ASSESSMENT DONE IMMEDIETLY, AFTER 2 HRS AND AFTER 6 HRS OF EXTUBATION.—

Secondary

MeasureTime frame
TIME REQUIRED FOR EXTUBATION.Timepoint: FROM CUTTING THE INHALATIONAL AGENTS AND GIVING INJ SUGAMMADEX AS REVERSAL TO EXTUBATION.—

Countries

India

Contacts

Public ContactDR VIDYA PATIL

BLDE DU,SHRI.B.M.PATIL MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTER,VIJAYPURA

Vidya.tambake@bldedu.ac.in9448131260

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026